Limited penetration depth into tumor tissues continues to hinder the development of nanotherapeutics for cancer treatment. A novel self-propelled ferroptosis nanoinducer developed by Southern Medical University was able to ...
Natural enzymes are remarkable molecular machines that enable all sorts of essential biochemical reactions. For decades, scientists have sought to create artificial versions of these catalysts for industrial and biomedical ...
A new study led by Profs. Fan Kelong and Yan Xiyun from the Institute of Biophysics of the Chinese Academy of Sciences introduces a novel ferritin-based delivery system for small interfering RNA (siRNA) targeting glioblastoma ...
Novel protein cage systems can control and visualize orientational changes in aromatic side chains upon ligand binding, as reported by researchers at the Institute of Science, Tokyo. By inducing coordinated molecular changes, ...
A collaborative study published on January 21 in Nature Communications presents a novel strategy to improve the effectiveness of radiotherapy for nasopharyngeal carcinoma (NPC).
Microscopy has been making leaps and bounds in recent years. Science that was inconceivable a few years ago has become a matter of programming state-of-the-art microscopes to process reams of data. Dr. Gabriel Frank quickly ...
A new way to deliver drugs using a common protein could be used to develop mosaic vaccines, which are vaccines effective against multiple strains of a virus like COVID-19, among other medicines in a global first.
Chattering squirrels, charming coypus, and tail-slapping beavers—along with some other rodents—have orange-brown front teeth. Researchers have published high-resolution images of rodent incisors in ACS Nano, providing ...
Cells rely on complex molecular machines composed of protein assemblies to perform essential functions such as energy production, gene expression, and protein synthesis. To better understand how these machines work, scientists ...
Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.
